Polyclonal anti-tumor necrosis factor-α Fab used as an ancillary treatment for severe malaria
Single doses (250, 500, 1,000, or 2,000 units/kg) of an ovine polyclonal-specific Fab fragment directed against tumor necrosis factor-α (TNF-α) were given to 17 adult patients with severe falciparum malaria immediately before treatment with artesunate in a pilot study to assess safety and optimal do...
Saved in:
Main Authors: | S. Looareesuwan, L. Sjostrom, S. Krudsood, P. Wilairatana, R. S. Porter, F. Hills, D. A. Warrell |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/25479 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand
by: S. Looareesuwan, et al.
Published: (2018) -
Tumour necrosis factor-α as a prognostic biomarker of severe malaria: a systematic review and meta-analysis
by: Aongart Mahittikorn, et al.
Published: (2022) -
Identification of a new receptor subtype for tumor necrosis factor-α
by: Schwalb, D.M., et al.
Published: (2014) -
Strong association of a tumor necrosis factor-α promoter allele with cerebral malaria in Myanmar
by: R. Ubalee, et al.
Published: (2018) -
Schizontemia as an indicator of severe malaria
by: Noppadon Tangpukdee, et al.
Published: (2018)